Skip to content

DART study shows HIV treatment without lab monitoring safe, effective in Africa

New measures of cardiovascular dysfunction in people with HIV pose new questions

Getting people onto treatment, not earlier treatment, must be priority, conference warned

Innovative, cost-effective and patient-friendly methods for delivery of HIV care feasible in resource-limited settings

Further evidence of needless treatment switches in absence of viral load testing

Raltegravir approved for first-line HIV treatment in US

Immune suppression increases risk of death from non-AIDS-defining illnesses

Stepped doses reduce incidence and severity of efavirenz-related side-effects

HIV treatment and traditional risk factors causing hardening of the arteries